FDA approves Regeneron drug for rare disorders
2/27/2008
U.S. regulators on Wednesday
approved a new drug to be sold by Regeneron Pharmaceuticals Inc
to treat certain chronic but rare inherited inflammatory
disorders.
More: - Read More
Share and enjoy
Post Comment
Entry 1 of 16100
Last Page | Next Page